- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
TMO
MEX
Week ended 24 Jul 2026
Weekly Investor Report
Thermo Fisher Scientific Inc. · Healthcare · Diagnostics & Research
Latest close
10,064 MXN
8.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 11.2% above the Trend Line and sits at 67.0% of its 52-week range. The latest completed week returned 8.7%, after a 13.0% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
54
out of 100
Latest Close
10,064 MXN
24 Jul 2026
1W Return
8.7%
latest completed week
4W Return
13.0%
short-term follow-through
12W Return
22.7%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.7%
Latest completed week; four-week move 13.0%.
Indicator stack
19/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
36 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 11.2% above the Trend Line and sits at 67.0% of its 52-week range. The latest completed week returned 8.7%, after a 13.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1712-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 13.0% over four weeks, 22.7% over 12 weeks, and 12.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.96Latest activity-pressure read.
Pressure change494.4%Four-week change in activity pressure.
Leadership5.27Latest relative-leadership reading.
RS change165.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 36 relevant articles.
13 positive · 20 neutral · 3 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.8%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher12 of 2612 weeks finished lower.
Best week+11.6%Week of 29 May.
Worst week-14.6%Week of 6 Feb.
Latest week+8.7%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks2
Modest losses6
Sharp losses6
Recent vol5.3%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split25/24Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank5 / 78
Group average0.9%
Trend breadth26.9%
Trend26.9%active weekly trend signals
MD61.5%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryMX Diagnostics & Research
4-week rank1 / 10
Group average3.9%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS30.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape48/100
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis23/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 1/12.
Activity pressure 0.17; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment55/100Weighted news tone is neutral across 36 relevant articles.
Thermo Fisher Scientific Inc (TMO) Shares Surge 3.0% -- What GF Score of 85 Tells Investors Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 10,064 MXN | 8.7% | 9,046 MXN | 9,634 MXN | 0.96 | 5.27 | 132 | Off |
| 17 Jul 2026 | 9,256 MXN | 0.7% | 9,057 MXN | 9,632 MXN | 0.88 | -3.61 | 31 | Off |
| 10 Jul 2026 | 9,190 MXN | -0.0% | 9,091 MXN | 9,634 MXN | 0.67 | -4.08 | 21 | Off |
| 3 Jul 2026 | 9,193 MXN | 3.2% | 9,132 MXN | 9,632 MXN | 0.52 | -4.93 | 4.6K | Off |
| 26 Jun 2026 | 8,910 MXN | 10.5% | 9,172 MXN | 9,629 MXN | 0.16 | -8.10 | 1.2K | Off |
| 19 Jun 2026 | 8,064 MXN | -5.2% | 9,239 MXN | 9,629 MXN | 0.08 | -17.45 | 0 | Off |
| 12 Jun 2026 | 8,504 MXN | 2.9% | 9,326 MXN | 9,635 MXN | -0.15 | -13.42 | 0 | Off |
| 5 Jun 2026 | 8,266 MXN | -3.8% | 9,399 MXN | 9,639 MXN | -0.44 | -13.63 | 0 | Off |
| 29 May 2026 | 8,597 MXN | 11.6% | 9,476 MXN | 9,643 MXN | -0.70 | -13.46 | 3.8K | Off |
| 22 May 2026 | 7,704 MXN | 1.4% | 9,538 MXN | 9,647 MXN | -1.08 | -22.26 | 185 | Off |
| 15 May 2026 | 7,599 MXN | -4.2% | 9,632 MXN | 9,655 MXN | -1.05 | -23.09 | 1.1K | Off |
| 8 May 2026 | 7,932 MXN | -3.3% | 9,709 MXN | 9,666 MXN | -1.00 | -22.13 | 708 | Off |
| 1 May 2026 | 8,200 MXN | 3.0% | 9,769 MXN | 9,674 MXN | -0.94 | -17.44 | 718 | Off |
| 24 Apr 2026 | 7,963 MXN | -12.8% | 9,828 MXN | 9,684 MXN | -0.93 | -21.71 | 5.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.